Two Sigma Securities’s PAVmed PAVM Stock Holding History

Two Sigma Securities’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-841	Closed	-$20.6K	–	3443
2024 Q2	$20.6K	Buy	+841	New	+$41.9K	﹤0.01%	2694
2023 Q4	–	Sell	-118	Closed	-$15.6K	–	3442
2023 Q3	$15.6K	Buy	+118	New	+$18.3K	﹤0.01%	2612
2022 Q1	–	Sell	-22	Closed	-$25K	–	2396
2021 Q4	$25K	Buy	+22	New	+$47.8K	﹤0.01%	1382
2019 Q1	–	Sell	-40	Closed	-$17K	–	2272
2018 Q4	$17K	Buy	+40	New	+$19.6K	﹤0.01%	1983

Other funds holding PAVM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Securities's PAVM Position: Q3 2024 in Review

Two Sigma Securities sold out of PAVmed (PAVM) in Q3 2024, closing a stake of 841 shares — an estimated $20.6K sold.

Two Sigma Securities first reported a position in PAVM in Q4 2018 and held it in 4 quarters. The position peaked at $25K in Q4 2021. 19 funds tracked by Wall St. Rank hold PAVM as of Q3 2024.

Two Sigma Securities reported no remaining PAVmed position as of Q3 2024 after selling out during the quarter.
Two Sigma Securities sold 841 PAVmed shares in Q3 2024, an estimated $20.6K.
Two Sigma Securities first reported a position in PAVmed in Q4 2018 and held it in 4 quarters.
Two Sigma Securities's PAVmed position peaked at $25K in Q4 2021.
19 funds tracked by Wall St. Rank held PAVmed as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.